New patent for Boehringer Ingelheim drug SYNJARDY XR

Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent for Boehringer Ingelheim drug SYNJARDY XR appeared…


New patent for Taiho Oncology drug LYTGOBI

Annual Drug Patent Expirations for LYTGOBI Lytgobi is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Taiho Oncology drug LYTGOBI appeared first on DrugPate…


Biotechblog